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Abstract  
 
Purpose To determine the diagnostic accuracy of quantitative real-time PCR assay in 
diagnosing bacterial vaginosis versus the standard methods: Amsel criteria and Nugent score.  
Methods Amsel criteria, Nugent score, and results from the molecular tool were obtained 
independently from vaginal samples of 163 pregnant women who reported abnormal vaginal 
symptoms before 20 weeks' gestation. To determine the performance of the molecular tool, 
we calculated the kappa value, sensitivity, specificity and positive and negative predictive 
values.  
Results Either or both of the Amsel criteria ( 3 criteria) and the Nugent score (score  7) 
indicated that 25 women (15%) had bacterial vaginosis; the remaining 138 women did not. 
DNA levels of Gardnerella vaginalis or of Atopobium vaginae exceeded 10
9
 copies/mL or 
10
8
 copies/mL, respectively, in 34 (21%) of the 163 samples. Complete agreement between 
both reference methods and high concentrations of G. vaginalis and A. vaginae was found in 
94.5% (154/163 samples, kappa value = 0.81, 95% confidence interval 0.70-0.81). The nine 
samples with discordant results were categorized as intermediate flora by the Nugent score. 
The molecular tool predicted bacterial vaginosis with a sensitivity of 100%, a specificity of 
93%, a positive predictive value of 73%, and a negative predictive value of 100%.  
Conclusions The quantitative real-time PCR assay shows excellent agreement with the results 
of both reference methods for the diagnosis of bacterial vaginosis.  
 
Keywords: Atopobium vaginae; Bacterial vaginosis; Diagnostic accuracy; Gardnerella 
vaginalis; PCR-based test; Pregnancy 
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Introduction 
Bacterial vaginosis (BV) is a common cause of vaginal symptoms in women of reproductive 
age 1. Mounting evidence associates BV, determined by clinical Amsel criteria or the Gram 
stain-based Nugent score, with susceptibility to sexually transmitted diseases, pelvic 
inflammatory diseases, preterm labor and preterm delivery 2. Unfortunately, although BV is 
associated with adverse pregnancy outcomes, regardless of the presence of clinical symptoms, 
the benefits of screening for and treating BV in pregnant women remain unclear 3-5. The 
subjective clinical diagnosis is of limited value in assessing an asymptomatic population, and 
half the women with BV are asymptomatic 6. The artificial Nugent score category of 
intermediate flora has increased the complexity of the clinical approach to vaginal flora: a 
significant percentage of the women tested have an intermediate score, but this category 
remains remarkably uncharacterized 7,8,9. Consequently obstetricians and gynaecologists 
continue to seek a reliable method for an objective analysis of abnormal vaginal flora.  
Recent advances in molecular techniques have increased our knowledge of the microbial 
ecosystem of BV and associated some bacteria with BV for the first time 10,11. Of these, 
one of the most interesting may be Atopobium vaginae, an anaerobic and fastidious bacteria 
recently reported to be highly associated with BV 10,12,13. Specific proportions of different 
Lactobacillus species are related to the overgrowth of particular BV-associated bacteria, with 
the disappearance of Lactobacillus species related to the development of Gardnerella 
vaginalis and A. vaginae, in particular 12,13. Although G. vaginalis and A. vaginae are both 
commonly present in normal flora, high vaginal concentrations of both are highly specific for 
BV 12,13. We previously proposed a reliable and accurate molecular tool based on the 
combination of high vaginal quantification of G. vaginalis (DNA level  109 copies/mL) and 
A. vaginae (DNA level  108 copies/mL). It resulted in sensitive and specific BV diagnosis 
when the Gram stain-based Nugent score was used as the gold standard 14. One of the 
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limitations of that study, however, was it did not apply a clinical approach to vaginal flora, by 
using the Amsel criteria, an alternative and commonly accepted diagnostic method for BV, as 
previous molecular studies have done 11,13,15. 
The aim of the present study was to compare the diagnostic accuracy of the quantitative real-
time PCR assay for G. vaginalis and A. vaginae for the diagnosis of BV with the two most 
commonly accepted methods, the Amsel criteria and the Nugent score. 
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Materials and Methods 
 
A prospective study of pregnant women took place at the North University Hospital of 
Marseille (France). Pregnant women were enrolled from September 2008 to November 2009. 
Vaginal samples were used to screen for BV in women who reported abnormal vaginal 
symptoms before 20 weeks' gestation. We selected only women with singleton pregnancies 
and for whom vulvovaginal candidiasis, trichomoniasis and gonococcal infection were ruled 
out after clinical examination and laboratory tests. The University's institutional review board 
(Ethics Committee of the University of Aix-Marseille, France) approved the study (in a 
decision dated September 19, 2008), and all participants provided written informed consent. 
 
Before vaginal sampling, the physician performed a speculum examination to note the 
appearance of the vaginal discharge, the spontaneous vaginal odour, and the odour after the 
addition of 10% potassium hydroxide. Vaginal pH was measured with pH strips and a 
colourimetric scale. After the clinical examination, the physicians took two vaginal samples 
from each woman at the same time, on two different sterile cytobrushes rotated against the 
vaginal wall (Scrinet, 5.5 mm, Laboratory CCD International, Paris, France). One sample 
from the first cytobrush was rolled onto a glass slide for Gram staining with an automated 
stainer (Model 7320 Aerospray Gram Slide Stainer; Wescor, Logan, UT) and Nugent scoring. 
The second cytobrush was transferred to a sterile tube containing 500 µl of BME Baral 
Medium (Invitrogen, Carlsbad, CA) and stored at –80°C until DNA extraction and molecular 
quantification.  
 
The two methods used to diagnose BV were (1) clinical diagnosis, based on the combination 
of any three of the following four criteria 16: vaginal pH greater than 4.5, thin homogeneous 
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vaginal discharge, clue cells on microscopic examination of vaginal fluid, and "fishy" amine 
odour after the addition of 10% potassium hydroxide (positive “whiff” test); (2) 
microbiological diagnosis, based on Gram staining graded according to the Nugent score 17 
to determine the presence of normal (score of 0 to 3) or intermediate flora (score of 4 to 6), or 
BV (score of 7 to 10). Clinicians and laboratory staff made their diagnoses independently, 
unaware of each other’s results.  
 
The quantitative molecular tool was based on a specific quantitative real-time polymerase 
chain reaction (qPCR) assay and serial dilutions of a plasmid suspension, as previously 
described 14. It targeted Lactobacillus species, A. vaginae, G. vaginalis, and a human 
albumin gene. Human albumin gene quantification was used as an internal control to 
provide evidence for DNA presence and DNA quality. Briefly, after DNA extraction, a 
qPCR assay was performed with a Stratagene MX 3000P (Agilent, La Jolla, CA). The 
amplification program was run at 50°C for 2 min and at 95°C for 15 min, followed by 45 
cycles at 95°C for 30 s and at 60°C for 1 min. Five µL of (1) a pure undiluted DNA sample, 
(2) a DNA sample diluted to 1/10 µL, (3) a DNA sample diluted to 1/100 µL, or (4) the 
serially diluted plasmid suspension was added to the 20-µL PCR mix that contained the 
Quantitect Probe PCR Kit mix (Qiagen, Courtaboeuf, France), the two pairs of primers, the 
two probes, and 100 U Uracil DNA glycosylase (Sigma-Aldrich, Saint Quentin Fallavier, 
France). All plasmid scale solutions were tested in duplicate. Negative controls were 
introduced in each reaction plate. To validate the quality and reproducibility of each PCR 
result, we verified for each reaction plate of each sample that (1) the standard curve remained 
linear and reproducible, (2) the cycle threshold values for all microorganisms tested in 
undiluted and diluted samples were reproducible and linear, and (3) the range of values for the 
number of albumin copies in the vaginal samples used as an internal control was narrow. The 
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quality and reproducibility of each PCR result were validated, and none of the 163 samples 
used in this study had to be excluded. The quantitative molecular tool made it possible to 
reduce the detection limit for all microorganisms to 10 copies per 5 µL (10
3
 copies per mL). 
The final results were expressed as copies of microorganism DNA per mL of vaginal 
suspension.  
 
To determine the accuracy of the molecular tool for the diagnosis of BV, the subjects were 
subsequently classified into two groups according to each method for diagnosing BV 
described above (Amsel criteria and Nugent score): those with BV and those without BV. 
Agreement between the two reference methods and high vaginal concentrations of A. vaginae 
(DNA level  108 copies/mL) and G. vaginalis (DNA level  109 copies/mL) was calculated 
with the kappa value, determined by the javastat online statistics package 18. A kappa of 1.0 
indicates perfect agreement. Values greater than 0.75 represent excellent agreement and 
values 0.40-0.75 fair to good agreement 19. The sensitivity, specificity, and predictive 
values of A. vaginae DNA  108 copies/mL and G. vaginalis DNA  109 copies/mL to predict 
BV were compared with reference methods. The statistical analysis used the UBC Bayesian 
Calculator Type 2 20. 
 
Results  
 
The study included all 163 pregnant women. The mean age of the study population was 29 
(±7) years. All women included had speculum examinations during which vaginal samples 
were taken. The Amsel criteria, Nugent score and molecular quantification of Lactobacillus 
species, G. vaginalis, A. vaginae, and human albumin gene were successfully obtained for 
each woman.  
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Table 1 reports the BV results according to both reference methods. Fifteen women had BV 
according to both the Amsel criteria and Nugent score, while 10 had discordant results 
according to these two methods: (i) 5 women had normal flora according to Amsel criteria but 
a Nugent score  7; (ii) 5 women had BV according to Amsel criteria but a Nugent score < 7. 
In all, 25 (15%) of the 163 women had BV according to at least one of these methods. The 
remaining 138 women (85%) did not have BV, as shown by both methods.  
 
The molecular characteristics of the vaginal flora are reported in Tables 2 and 3. No 
Lactobacillus species was detected by the qPCR method in 32 (19.60%) of the 163 samples. 
The DNA level of G. vaginalis equalled or exceeded 10
9
 copies/mL for 22 women (13.5%), 
and that of A. vaginae equalled or exceeded 10
8
 copies/mL for 30 (18.40%). In all, 34 (21%) 
of the 163 samples had high vaginal concentrations of G. vaginalis or A. vaginae or both. The 
molecular profile of the 25 samples of vaginal flora identified as BV by either the Amsel 
criteria or Nugent score is presented in Table 3: 18 had no Lactobacillus species detected by 
qPCR, and all had high vaginal concentrations of G. vaginalis or A. vaginae or both.  
 
Complete agreement between both reference methods for diagnosing BV and the molecular 
tool (that is, high vaginal concentrations of G. vaginalis or A. vaginae) occurred in 94.5% 
(154/163 samples). There was disagreement for nine samples (5.5%). All nine had high 
vaginal concentrations of G. vaginalis ( 109 copies/mL) or A. vaginae ( 108 copies/mL), did 
not have BV according to the Amsel criteria, and were categorized as intermediate flora by 
the Nugent score (Table 2). There was substantial agreement (kappa=0.81; 95% confidence 
interval 0.70-0.81) between the reference methods and high vaginal concentrations of both 
microorganisms. Compared with the reference methods, the molecular tool had a sensitivity 
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 9 
of 100%, a specificity of 93%, a positive predictive value of 73% and a negative predictive 
value of 100% for predicting BV (Table 4). 
 
Discussion 
 
We examined the accuracy of a quantitative real-time PCR assay for G. vaginalis and A. 
vaginae for the diagnosis of BV compared with both the Amsel criteria and the Nugent score, 
both reference methods for this diagnosis. The originality of the present study is its 
simultaneous consideration of both the clinical characteristics of vaginal flora, according to 
the Amsel criteria, and the categorization of vaginal flora, according to the Gram stain-based 
Nugent score, to determine the accuracy of the molecular tool for diagnosing BV.  
 
Good agreement (kappa=0.81) and high sensitivity (100%) and specificity (93%) were 
reported for the molecular tool in relation to both reference methods. These findings 
demonstrate the interest of molecular prediction of BV. The advantage of our PCR-based test 
is its ability to predict BV accurately when the standard methods result in false negatives. In 
this study, of the 25 flora samples with BV, 10 (40%) had discordant results for the Amsel 
criteria and the Nugent score (Table 3). Five samples categorized as BV by the Nugent score 
were normal according to the Amsel criteria. Those results are not surprising because the 
sensitivity of Amsel criteria for BV diagnosis is reported to be poor 21. For the Nugent 
score, 5 samples categorized as BV by the Amsel criteria were rated intermediate according to 
the Nugent score. The Nugent scoring system is excellent in diagnosing samples as either 
normal or BV, but the intermediate flora presents problems 7,8. Vaginal smears with 
intermediate flora may be considered as heterogeneous flora that most commonly include 
normal flora rather than BV, according to the definition of Amsel criteria 22. Furthermore, 
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recent PCR assays report the heterogeneous character of intermediate flora, with some of 
them suggesting a molecular profile more similar to that of BV than to normal samples 
13,14. 
 
The molecular criteria’s lower positive predictive value of 73% suggests that some positive 
molecular results are false positives (5.5%), i.e., although the molecular profiles of G. 
vaginalis and A. vaginae are identical to those seen in BV patients, the women do not meet 
the clinical ( 3 Amsel criteria) or microbiologic criteria (Nugent score  7) that define BV 
(Table 2). Alternatively, however, these results may represent true positives for the molecular 
condition of BV that were missed by traditional diagnostic tools. The false negatives of both 
standard methods reported above may support this alternative explanation. In any case, our 
molecular tool, based on PCR quantification of G. vaginalis and A. vaginae, clearly defines a 
reproducible and standardized molecularly defined BV, irrespective of the clinical and 
microscopic characteristics of vaginal flora. The clinical implications of this molecular 
condition should help to improve our understanding of BV, especially during pregnancy. 
Thus, we recently reported that high vaginal concentrations of G. vaginalis and A. vaginae are 
associated with a significant risk of preterm delivery in women with preterm labor 23. 
 
Some points must be discussed as potential limitations of our study. First, we did no attempt 
to test for each bacterial species known to be found in the vagina, but the spectrum of targeted 
microorganisms is significant in BV. It is possible that quantification of additional vaginal 
microorganisms would modify the results. Second, repeat vaginal sampling to detect changes 
in the vaginal flora could provide valuable information about the pathogenesis and natural 
history of the molecular condition of BV. Third, quantitative PCR assays have recently 
demonstrated a substantial variability in G. vaginalis levels with menstrual cycle 24. 
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Consequently, the same threshold established in amenorrheic pregnant women may not 
be appropriate for non-pregnant women. In conclusion, comparison with the reference 
methods of the Amsel criteria and the Nugent score shows that the quantitative real-time PCR 
assay, targeting G. vaginalis and A. vaginae, is a reliable tool for the diagnosis of BV. The 
pathogenesis of the molecular condition of BV should be investigated.  
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Table 1: Characteristics of vaginal flora according to the Amsel criteria and Nugent score.  
 
Methods for diagnosis Women with 
bacterial vaginosis 
Women without bacterial vaginosis 
Normal flora Intermediate flora 
Amsel criteria 20 (12%) 143 (88%) - 
Nugent score 20 (12%) 117 (72%) 26 (16%) 
Amsel criteria and Nugent score 15 (9.2%) 117 (72%) - 
Amsel criteria or Nugent score 25 (15%) 117 (72%) 21 (13%) 
 
 
 
 
Table
 2 
Table 2: Molecular characteristics of vaginal flora for women with bacterial vaginosis (n=25) 
and without bacterial vaginosis (n=138), with the Amsel criteria and Nugent score as 
reference methods. 
 
PCR quantification 
(bacteria/mL) 
Women with 
bacterial vaginosis 
n=25 
Women without bacterial vaginosis 
n=138 
Normal flora 
n=117 
Intermediate flora 
n=21 
No Lactobacillus species 18 (72%) 8 (6.8%) 6 (28%) 
G. vaginalis  109/mL  18 (72%) 0 4 (19%) 
A. vaginae  108/mL 24 (96%) 0 6 (28%) 
G. vaginalis  109/mL and/or  
A. vaginae  108/mL 
25 (100%) 0 9 (43%) 
 3 
Table 3: Molecular loads for Lactobacillus species, Gardnerella vaginalis and Atopobium 
vaginae for women with bacterial vaginosis (n=25) according to Amsel criteria ( 3 criteria) 
or Nugent score (score  7).  
 
 Method for diagnosis PCR quantification (bacteria/mL) 
N Amsel criteria Nugent score Lactobacillus G. vaginalis A. vaginae 
1 BV BV - 1.15 x10
9
 1.09 x10
8
 
2 BV BV 1.83 x10
3
 2.69 x10
10
 5.31 x10
8
 
3 BV BV - 1.19 x10
9
 8.73 x10
8
 
4 BV BV - 4.47 x10
8
 8.34 x10
10
 
5 BV BV - 4.73 x10
9
 4.84 x10
9
 
6 BV BV 2.38 x10
8
 - 1.40 x10
9
 
7 BV BV - 6.32 x10
8
 2.30 x10
9
 
8 BV BV - 1.88 x10
9
 7.20 x10
8
 
9 BV BV 9.20 x10
5
 3.10 x10
9
 1.07 x10
9
 
10 BV BV - 1.80 x10
9
 2.20 x10
9
 
11 BV BV - 2.60 x10
8
 7.60 x10
8
 
12 BV BV - 7.75 x10
9
 1.05 x10
8
 
13 BV BV - 1.40 x10
9
 1.30 x10
8
 
14 BV BV - 3.40 x10
9
 1.50 x10
9
 
15 BV BV 5.67 x10
8
 3.05 x10
9
 6.16 x10
9
 
16 BV IF 2.38 x10
9
 - 2.04 x10
9
 
17 BV IF - 1.02 x10
9
 4.80 x10
8
 
18 BV IF - 5.67 x10
9
 1.52 x10
9
 
19 BV IF - 3.42 x10
9
 6.87 x10
9
 
20 BV IF - 1.80 x10
9
 1.80 x10
8
 
21 NF BV - 5.30 x10
9
 1.14 x10
9
 
22 NF BV - - 2.04 x10
8
 
23 NF BV - 1.56 x10
10
 1.05 x10
9
 
24 NF BV 3.78 x10
8
 5.41 x10
9
 3.82 x10
7
 
25 NF BV 2.44 x10
7
 1.50 x10
8
 2.00 x10
8
 
 
BV: Bacterial Vaginosis; NF: Normal Flora; IF: Intermediate Flora. 
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Table 4: Sensitivity, specificity and predictive values with 95% confidence intervals of the 
PCR quantification for the prediction of bacterial vaginosis among women with bacterial 
vaginosis (n=25) and without bacterial vaginosis (n=138), with the Amsel criteria and Nugent 
score as reference methods. 
 
Microorganism threshold 
quantification to predict 
bacterial vaginosis 
% (95% confidence intervals) 
 
Sensitivity 
 
Specificity 
Predictive value 
Positive Negative 
G. vaginalis  109/mL 0.72  
(0.54-0.90) 
0.97  
(0.94-0.99) 
0.82  
(0.66-0.98) 
0.95  
(0.91-0.99) 
A. vaginae  108/mL 0.96  
(0.88-1) 
0.96  
(0.92-0.99) 
0.80  
(0.66-0.94) 
0.99  
(0.98-1) 
G. vaginalis  109/mL and/or  
A. vaginae  108/mL 
1 0.93  
(0.89-0.97) 
0.73  
(0.59-0.88) 
1 
 
 
